These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 11959201

  • 1. Role of immunosuppressive treatments based on mycophenolate mofetil in posttransplantation renal surgical complications.
    Herrero JC, Andrés A, Leiva O, Diaz R, Polo G, Aguirre F, Villacampa F, Rodicio JL, Gonzalez E, Morales JM, Praga M.
    Transplant Proc; 2002 Feb; 34(1):96. PubMed ID: 11959201
    [No Abstract] [Full Text] [Related]

  • 2. Treatment with mycophenolate mofetil in kidney transplant patients with organs from donors aged over 60 years: one-year monitoring results.
    Agraz I, Guirado L, Andrade M, Olaya M, Vila A, Solá R.
    Transplant Proc; 1999 Sep; 31(6):2272-4. PubMed ID: 10500573
    [No Abstract] [Full Text] [Related]

  • 3. Decreased rejection episodes in African-American renal transplant recipients receiving mycophenolate mofetil/tacrolimus therapy.
    Weber M, Deng S, Arenas J, Aradhye S, Grossman R, Shaw L, Naji A, Barker C, Brayman KL.
    Transplant Proc; 1997 Dec; 29(8):3669-70. PubMed ID: 9414883
    [No Abstract] [Full Text] [Related]

  • 4. Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation.
    Bruce DS, Woodle ES, Newell KA, Millis JM, Cronin DC, Loss GE, Grewal HP, Siegel CT, Pellar S, Josephson MA, Thistlethwaite JR.
    Transplant Proc; 1998 Jun; 30(4):1538-40. PubMed ID: 9636625
    [No Abstract] [Full Text] [Related]

  • 5. Immunosuppression using tacrolimus/mycophenolate versus neoral/mycophenolate following kidney transplantation: a single-center experience.
    Urbizu JM, Amenabar JJ, Gomez-Ullate P, Zarraga S, Lampreabe I.
    Transplant Proc; 2002 Feb; 34(1):87-8. PubMed ID: 11959197
    [No Abstract] [Full Text] [Related]

  • 6. Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving Prograf and CellCept in combination therapy.
    Zucker K, Rosen A, Tsaroucha A, de Faria L, Roth D, Ciancio G, Esquenazi V, Burke G, Tzakis A, Miller J.
    Transplant Proc; 1997 Feb; 29(1-2):334-6. PubMed ID: 9123027
    [No Abstract] [Full Text] [Related]

  • 7. Steroid withdrawal in renal transplant recipients.
    Oppenheimer F.
    Transplant Proc; 2000 Feb; 32(1A Suppl):14S-15S. PubMed ID: 10686314
    [No Abstract] [Full Text] [Related]

  • 8. Randomized trial of tacrolimus in combination with mycophenolate mofetil versus cyclosporine with mycophenolate mofetil in cadaveric renal transplant recipients with delayed graft function.
    Liu B, Lin ZB, Ming CS, Zhang WJ, Chen ZS, Sha B, Zeng FJ, Chen S.
    Transplant Proc; 2003 Feb; 35(1):87-8. PubMed ID: 12591319
    [No Abstract] [Full Text] [Related]

  • 9. A prospective randomised study of CSA monotherapy versus CSA plus mycophenolate mofetil in cadaveric renal transplant recipients.
    Sells RA, Bakran A, Brown MW, Grinyo J, Hammad A, Hyatt D, Owens G.
    Transplant Proc; 1998 Dec; 30(8):4098. PubMed ID: 9865311
    [No Abstract] [Full Text] [Related]

  • 10. Chronic allograft nephropathy: prospective randomised trial of cyclosporin withdrawal and mycophenolate mofetil or tacrolimus substitution.
    McGrath JS, Shehata M.
    Transplant Proc; 2001 May; 33(3):2193-5. PubMed ID: 11377500
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group.
    Forsythe J.
    Transplant Proc; 1999 Nov; 31(7A):69S-71S. PubMed ID: 10576049
    [No Abstract] [Full Text] [Related]

  • 13. Tacrolimus/"low-dose" mycophenolate mofetil versus microemulsion cyclosporine/"low-dose" mycophenolate mofetil after kidney transplantation--1-year follow-up of a prospective, randomized clinical trial.
    Yang HC, Holman MJ, Langhoff E, Ulsh PJ, Dellock CA, Gupta M, Ahsan N.
    Transplant Proc; 1999 Nov; 31(1-2):1121-4. PubMed ID: 10083501
    [No Abstract] [Full Text] [Related]

  • 14. Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 de Octubre, Madrid.
    Morales JM, Andrés A, Morales E, Herrero JC, Cubas A, Praga M, Hernández E, Ortuño T, Dominguez-Gil B, Carreño A, Delgado M, Manzanares C.
    Transplant Proc; 1999 Nov; 31(7A):75S-77S. PubMed ID: 10576051
    [No Abstract] [Full Text] [Related]

  • 15. Benelux experience with a combination of tacrolimus and mycophenolate mofetil: 4-year results.
    van Hooff JP, Squifflet JP, Vanrenterghem Y.
    Transplant Proc; 2002 Aug; 34(5):1591-3. PubMed ID: 12176498
    [No Abstract] [Full Text] [Related]

  • 16. Mycophenolate mofetil as maintenance immunosuppression in pediatric renal transplantation.
    Ettenger R, Cohen A, Nast C, Moulton L, Marik J, Gales B.
    Transplant Proc; 1997 Aug; 29(1-2):340-1. PubMed ID: 9123030
    [No Abstract] [Full Text] [Related]

  • 17. Triple therapy with mycophenolate mofetil, cyclosporine, and prednisone in renal transplantation.
    Crespo JF, Górriz JL, Sancho A, Avila A, Alcoy E, Pallardó LM.
    Transplant Proc; 1999 Sep; 31(6):2261-2. PubMed ID: 10500568
    [No Abstract] [Full Text] [Related]

  • 18. Mycophenolate mofetil, tacrolimus, Neoral: from clinical trials to the clinic.
    Pirsch JD.
    Transplant Proc; 1998 Aug; 30(5):2223-5. PubMed ID: 9723448
    [No Abstract] [Full Text] [Related]

  • 19. Mycophenolate mofetil in living donor renal allograft recipients.
    Park K, Moon JI, Kim SI, Kim YS.
    Transplant Proc; 1999 Aug; 31(1-2):1133. PubMed ID: 10083506
    [No Abstract] [Full Text] [Related]

  • 20. Improved immunosuppression with combination tacrolimus (FK506) and mycophenolic acid in orthotopic liver transplantation.
    Cai TH, Esterl RM, Nichols L, Cigarroa F, Speeg KV, Halff GA.
    Transplant Proc; 1998 Jun; 30(4):1413-4. PubMed ID: 9636572
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.